HIV Ages Immune Cell DNA by 14 Years
Untreated HIV causes changes to cellular DNA that are
akin to 14 years of aging, which may partially explain the early onset
of age-related diseases among people living with the virus. Publishing
their findings in PLOS ONE, researchers compared DNA extracted from
stored white blood cells of treatment-naive HIV-positive men between 20
and 56 years old with that of age-matched HIV-negative men, for a total
of 96 samples.
The researchers compared changes to cellular DNA that are strongly linked with aging to changes that take place during HIV disease, and used the overlap to estimate the age of the HIV-positive individuals who gave samples. They found that, according to their cellular DNA, these men seemed to be 14 years older than their chronological age.
“This number is in line with both anecdotal and published data suggesting that treated HIV-infected adults can develop the diseases of aging mentioned above, approximately a decade earlier than their uninfected peers,” Beth Jamieson, PhD, a professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and one of the study’s senior authors, said in a press release.
The researchers could not determine if antiretroviral therapy reverses such genetic changes, nor could they tell whether HIV treatment itself contributes to these changes.
To read the press release, click here.
To read the study, click here.
The researchers compared changes to cellular DNA that are strongly linked with aging to changes that take place during HIV disease, and used the overlap to estimate the age of the HIV-positive individuals who gave samples. They found that, according to their cellular DNA, these men seemed to be 14 years older than their chronological age.
“This number is in line with both anecdotal and published data suggesting that treated HIV-infected adults can develop the diseases of aging mentioned above, approximately a decade earlier than their uninfected peers,” Beth Jamieson, PhD, a professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and one of the study’s senior authors, said in a press release.
The researchers could not determine if antiretroviral therapy reverses such genetic changes, nor could they tell whether HIV treatment itself contributes to these changes.
To read the press release, click here.
To read the study, click here.
Search: HIV, cellular aging, PLOS ONE, Beth Jamieson.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.